Patient Pathfinder: Clinical Trials

Clinical Trial Finder Transthyretin Amyloid Cardiomyopathy Trials

Clinical Trials for Transthyretin Amyloid Cardiomyopathy

Every life-saving or life-extending treatment thatâ€™s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.

Clinical trials also give patients a chance to try a treatment before itâ€™s approved by the U.S. Food and Drug Administration.

See Locations Near You

There are 33 active Transthyretin Amyloid Cardiomyopathy trials

Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy

Study Type: Observational

A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

Study Type: Interventional Phase 2

Bronx Transthyretin Amyloid Cardiomyopathy Database

Study Type: Observational

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Study Type: Interventional Phase 3

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

Study Type: Interventional Phase 3

CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study

Study Type: Observational

The CARDIO-TTRansform Scintigraphy Sub-study

Study Type: Observational

Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis

Study Type: Observational

1 2 3 … 5 Next »

There are 33 active Transthyretin Amyloid Cardiomyopathy trials

Filter Results

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.